Where this pathway sits, and its limits
The Readiness Pathway is a nonpublic, pre-certification process. It runs before any certificate exists, so nothing on this page awards or affects a mark. It is a commercial and operational service, not legal advice, and it does not determine a brand’s reporting, recall, disclosure, or contractual obligations. Confidentiality here is not attorney-client privilege and is not a promise that relevant evidence can never be reached through lawful process. Where readiness testing surfaces a result that may present a legal or public-health issue, it is escalated to the brand’s own quality, food-safety, regulatory, and legal decision-makers; readiness never delays or obstructs a required action. A brand with a specific legal exposure should structure privileged work through its own counsel.
Why the pathway exists
Every certification faces the same problem. If the first interaction with a certifier is a pass-or-fail decision, the rational move for a brand that is unsure is to not look: to test less, ask fewer questions, and avoid learning things that create obligations. A program that punishes discovery gets less discovery, and the mark it issues ends up certifying how little a brand knows rather than how clean its product is.
The Readiness Pathway is the answer. It lets a brand read the target, learn where its product actually stands, and correct the cause, before committing to an official evaluation and before any public record exists. A product that is not yet certification-ready is not a rejected brand. It is a product that needs a defined reduction pathway first.
What readiness does
1. Map the requirement
HMTc identifies the standard that applies to the product in the form it is sold in, and shows the analytes, the limits, the basis, and the sampling and laboratory requirements before you commit. Existing laboratory reports are reviewed to reduce duplicated work, and are used only where their method, scope, units, laboratory competence, and sample identity suit the decision.
2. Learn where the product stands
Testing is sequenced to the product and the question. Where useful, it begins upstream, with incoming ingredients, supplier samples, developmental batches, packaging investigations, or held production lots, so an affected input or lot can be controlled before release. Your authorized team receives the exact quantitative results, not a bare pass-or-fail, along with what is needed to interpret them.
3. Correct the cause
A result that does not meet an HMTc limit is classified by context. A correctable finding enters a defined reduction process, which may include targeted ingredient testing, supplier review, origin comparison, process investigation, formulation assessment, or specification changes. The objective is not one favorable retest. It is a product and a control system that can stay within the limit under ordinary production variation.
When the product is ready, it moves to the official certification evaluation, which runs under its own sampling, chain-of-custody, laboratory, review, and decision rules. Readiness work does not award the mark; certification does, and only after the evidence demonstrates conformance.
What stays nonpublic
Requesting a readiness review or working a correctable finding does not create a public record. HMTc does not publish the identity of a brand merely for entering readiness, and it does not maintain a public list of brands that applied but were not yet ready to certify. A readiness nonconformity is not automatically an illegal, dangerous, or recalled product: HMTc limits may be more protective than the legal requirement in a given market, so a product can miss an HMTc limit while remaining fully compliant with the law. What readiness does not do is covered under what happens to your data and in the limits stated at the top of this page.
What qualifies for readiness
| Situation | In readiness |
|---|---|
| Brand wants to know whether a product can be certified | Yes; the intended case |
| An incoming ingredient or supplier sample needs screening before use | Yes; discovery moves upstream, where an input can still be controlled |
| A developmental or pilot batch needs evaluation before launch | Yes; formulation or source can be corrected before official evaluation |
| A held production lot needs checking before release | Yes; the lot can be controlled before it enters commerce |
| A result may indicate a legal or public-health issue | Escalated to the brand’s decision-makers, not handled quietly as a private-standard matter |
What the brand receives
| Deliverable | Decision it supports |
|---|---|
| Applicable-standard map | Which limits, basis, panel, and product form govern |
| Existing-evidence review | Which prior reports are usable, and where gaps remain |
| Product-specific testing plan | What to test, in what sequence, and for what purpose |
| Quantitative laboratory results | Where the measured product or input stands |
| Margin and trend assessment | Whether the product has enough operating headroom |
| Root-cause investigation plan | Which ingredients, suppliers, origins, or processes to examine |
| Corrective-action roadmap | What must change before the product is evaluated |
| Retest criteria | What evidence will show the correction is stable |
Beginning
Start by finding the standard that applies to your product. No company name is required to look one up. When you are ready to open a readiness review, it is handled confidentially from first contact, not from the moment an account exists.